View here
AstraZeneca, a global, science-led biopharmaceutical firm, spent $64.5M on a manufacturing plant that sits on a 228-acre site in Longmont from Amgen, Inc.
Image extracted from AstraZeneca R&D Image Library
Adaptive Reuse: A Steamboat Developer’s Answer to a Billion-Dollar Building Boom
By Chris Paoli, managing partner, The Agency Steamboat Springs Steamboat Springs is in the middle of its biggest development cycle
